Form 8-K - Current report:
SEC Accession No. 0001493152-23-016045
Filing Date
2023-05-10
Accepted
2023-05-10 07:30:18
Documents
13
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40300
2 ex99-1.htm EX-99.1 71525
  Complete submission text file 0001493152-23-016045.txt   299533

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sonn-20230510.xsd EX-101.SCH 3230
4 XBRL LABEL FILE sonn-20230510_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE sonn-20230510_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3616
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 23904339
SIC: 2834 Pharmaceutical Preparations